 Matthew Daley
Concepts (432)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 87 | 2024 | 1209 | 8.210 |
Why?
| | Vaccines | 35 | 2024 | 376 | 6.740 |
Why?
| | Influenza Vaccines | 40 | 2023 | 498 | 5.090 |
Why?
| | Immunization Schedule | 28 | 2024 | 184 | 3.990 |
Why?
| | Vaccination Coverage | 12 | 2023 | 63 | 3.820 |
Why?
| | Influenza, Human | 29 | 2023 | 549 | 3.620 |
Why?
| | Papillomavirus Vaccines | 15 | 2022 | 222 | 3.010 |
Why?
| | Immunization Programs | 17 | 2022 | 207 | 2.910 |
Why?
| | Papillomavirus Infections | 10 | 2022 | 258 | 2.650 |
Why?
| | Immunization | 22 | 2024 | 402 | 2.420 |
Why?
| | Adverse Drug Reaction Reporting Systems | 14 | 2022 | 69 | 2.280 |
Why?
| | Health Knowledge, Attitudes, Practice | 16 | 2021 | 1193 | 2.150 |
Why?
| | Advisory Committees | 17 | 2024 | 208 | 2.060 |
Why?
| | Electronic Health Records | 24 | 2023 | 805 | 2.030 |
Why?
| | Child, Preschool | 75 | 2023 | 9164 | 1.980 |
Why?
| | Patient Acceptance of Health Care | 13 | 2022 | 682 | 1.780 |
Why?
| | School Health Services | 11 | 2018 | 206 | 1.740 |
Why?
| | Eczema | 3 | 2022 | 83 | 1.730 |
Why?
| | Infant | 70 | 2024 | 7992 | 1.700 |
Why?
| | Parents | 15 | 2023 | 1208 | 1.690 |
Why?
| | Social Media | 4 | 2021 | 135 | 1.680 |
Why?
| | Child | 97 | 2024 | 18537 | 1.630 |
Why?
| | United States | 78 | 2024 | 12319 | 1.500 |
Why?
| | Humans | 204 | 2024 | 115859 | 1.410 |
Why?
| | Adolescent | 81 | 2024 | 17935 | 1.350 |
Why?
| | Pregnancy Complications, Infectious | 4 | 2022 | 289 | 1.340 |
Why?
| | Reminder Systems | 6 | 2016 | 162 | 1.330 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 10 | 2022 | 242 | 1.270 |
Why?
| | Female | 131 | 2023 | 60070 | 1.270 |
Why?
| | Practice Patterns, Physicians' | 16 | 2014 | 1182 | 1.260 |
Why?
| | Information Dissemination | 2 | 2020 | 192 | 1.130 |
Why?
| | Male | 114 | 2023 | 56103 | 1.120 |
Why?
| | Pediatric Obesity | 7 | 2022 | 492 | 1.080 |
Why?
| | Pediatrics | 17 | 2020 | 985 | 1.070 |
Why?
| | Measles | 3 | 2022 | 38 | 1.030 |
Why?
| | Colorado | 30 | 2022 | 4122 | 1.010 |
Why?
| | Product Surveillance, Postmarketing | 6 | 2017 | 63 | 1.000 |
Why?
| | Hypertension | 7 | 2018 | 1065 | 0.960 |
Why?
| | Body Mass Index | 13 | 2022 | 1974 | 0.940 |
Why?
| | Practice Guidelines as Topic | 13 | 2021 | 1405 | 0.930 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 9 | 2023 | 89 | 0.930 |
Why?
| | Thrombocytopenia | 3 | 2022 | 175 | 0.890 |
Why?
| | Data Collection | 16 | 2017 | 637 | 0.870 |
Why?
| | Asthma | 5 | 2022 | 2150 | 0.870 |
Why?
| | Attitude of Health Personnel | 13 | 2020 | 991 | 0.850 |
Why?
| | Egg Hypersensitivity | 1 | 2022 | 45 | 0.820 |
Why?
| | Pneumococcal Vaccines | 6 | 2022 | 132 | 0.810 |
Why?
| | Retrospective Studies | 35 | 2023 | 12615 | 0.790 |
Why?
| | Obesity | 7 | 2022 | 2523 | 0.780 |
Why?
| | Adult | 64 | 2024 | 30814 | 0.780 |
Why?
| | Ambulatory Care | 4 | 2020 | 479 | 0.770 |
Why?
| | Data Mining | 3 | 2022 | 100 | 0.770 |
Why?
| | Rotavirus Vaccines | 6 | 2022 | 48 | 0.750 |
Why?
| | Blood Pressure | 4 | 2018 | 1537 | 0.750 |
Why?
| | Whooping Cough | 6 | 2023 | 49 | 0.750 |
Why?
| | Anti-Bacterial Agents | 5 | 2022 | 1486 | 0.730 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 3 | 2018 | 25 | 0.730 |
Why?
| | Disabled Persons | 1 | 2022 | 135 | 0.730 |
Why?
| | Vaccination Refusal | 2 | 2018 | 69 | 0.720 |
Why?
| | Anti-Infective Agents, Urinary | 1 | 2020 | 13 | 0.710 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 362 | 0.710 |
Why?
| | Reimbursement Mechanisms | 3 | 2018 | 78 | 0.700 |
Why?
| | Education, Medical, Continuing | 1 | 2021 | 119 | 0.700 |
Why?
| | Geographic Information Systems | 1 | 2020 | 37 | 0.700 |
Why?
| | Syncope | 2 | 2017 | 36 | 0.690 |
Why?
| | Guideline Adherence | 7 | 2015 | 497 | 0.680 |
Why?
| | Young Adult | 41 | 2023 | 10508 | 0.680 |
Why?
| | Internet | 5 | 2018 | 601 | 0.670 |
Why?
| | Anaphylaxis | 3 | 2019 | 148 | 0.670 |
Why?
| | Information Storage and Retrieval | 2 | 2020 | 110 | 0.660 |
Why?
| | Family Practice | 8 | 2015 | 428 | 0.660 |
Why?
| | Peanut Hypersensitivity | 1 | 2022 | 201 | 0.660 |
Why?
| | Vaccines, Attenuated | 7 | 2023 | 113 | 0.630 |
Why?
| | Population Surveillance | 7 | 2020 | 395 | 0.630 |
Why?
| | Urinary Tract Infections | 1 | 2020 | 136 | 0.630 |
Why?
| | Incidence | 17 | 2021 | 2336 | 0.620 |
Why?
| | Rural Population | 3 | 2020 | 448 | 0.620 |
Why?
| | Healthcare Disparities | 1 | 2023 | 487 | 0.620 |
Why?
| | Delivery of Health Care | 5 | 2019 | 847 | 0.610 |
Why?
| | Cohort Studies | 27 | 2023 | 4960 | 0.610 |
Why?
| | Montana | 3 | 2023 | 16 | 0.610 |
Why?
| | Drug Hypersensitivity | 2 | 2019 | 86 | 0.590 |
Why?
| | Poliovirus Vaccine, Inactivated | 2 | 2014 | 22 | 0.580 |
Why?
| | Learning | 1 | 2021 | 358 | 0.580 |
Why?
| | Pregnant Women | 3 | 2023 | 132 | 0.570 |
Why?
| | Abortion, Spontaneous | 3 | 2023 | 92 | 0.570 |
Why?
| | Hepatitis B Vaccines | 3 | 2018 | 46 | 0.570 |
Why?
| | Surveys and Questionnaires | 13 | 2022 | 4673 | 0.560 |
Why?
| | Disease Outbreaks | 3 | 2011 | 308 | 0.550 |
Why?
| | Prehypertension | 2 | 2013 | 24 | 0.550 |
Why?
| | Databases, Pharmaceutical | 1 | 2016 | 5 | 0.540 |
Why?
| | Aluminum | 3 | 2022 | 34 | 0.540 |
Why?
| | Treatment Refusal | 3 | 2013 | 85 | 0.530 |
Why?
| | Computers, Handheld | 1 | 2016 | 24 | 0.520 |
Why?
| | Professional-Family Relations | 2 | 2015 | 138 | 0.520 |
Why?
| | Mothers | 2 | 2019 | 666 | 0.520 |
Why?
| | Urban Population | 2 | 2020 | 405 | 0.510 |
Why?
| | Overweight | 5 | 2020 | 468 | 0.500 |
Why?
| | Risk Assessment | 15 | 2022 | 2992 | 0.500 |
Why?
| | Seasons | 9 | 2023 | 450 | 0.490 |
Why?
| | Quality Assurance, Health Care | 3 | 2014 | 315 | 0.490 |
Why?
| | Consumer Health Information | 1 | 2015 | 47 | 0.490 |
Why?
| | Bias | 7 | 2021 | 181 | 0.490 |
Why?
| | Pregnancy | 14 | 2023 | 5555 | 0.490 |
Why?
| | Safety | 5 | 2018 | 298 | 0.480 |
Why?
| | Deductibles and Coinsurance | 1 | 2014 | 9 | 0.470 |
Why?
| | Age Factors | 11 | 2022 | 2911 | 0.470 |
Why?
| | Middle Aged | 42 | 2023 | 27078 | 0.460 |
Why?
| | Decision Making | 3 | 2018 | 790 | 0.460 |
Why?
| | Databases, Factual | 7 | 2019 | 1137 | 0.450 |
Why?
| | Primary Health Care | 10 | 2023 | 1520 | 0.440 |
Why?
| | Dental Hygienists | 1 | 2013 | 15 | 0.440 |
Why?
| | Pneumococcal Infections | 2 | 2022 | 91 | 0.430 |
Why?
| | Chronic Disease | 5 | 2022 | 1598 | 0.420 |
Why?
| | Drug Approval | 6 | 2021 | 78 | 0.420 |
Why?
| | Central Nervous System Stimulants | 1 | 2014 | 140 | 0.420 |
Why?
| | Health Care Surveys | 8 | 2013 | 540 | 0.410 |
Why?
| | Trust | 1 | 2013 | 108 | 0.410 |
Why?
| | Infant, Newborn | 13 | 2023 | 5084 | 0.400 |
Why?
| | Patient Compliance | 1 | 2016 | 524 | 0.400 |
Why?
| | Measles-Mumps-Rubella Vaccine | 5 | 2022 | 41 | 0.400 |
Why?
| | Vaccines, Inactivated | 6 | 2020 | 68 | 0.390 |
Why?
| | Attitude to Health | 4 | 2018 | 409 | 0.380 |
Why?
| | Haemophilus Vaccines | 3 | 2020 | 27 | 0.380 |
Why?
| | Community Health Services | 1 | 2013 | 212 | 0.380 |
Why?
| | Myocarditis | 2 | 2022 | 95 | 0.370 |
Why?
| | Licensure, Medical | 1 | 2010 | 12 | 0.370 |
Why?
| | Risk Factors | 14 | 2020 | 8715 | 0.360 |
Why?
| | Hepatitis B | 2 | 2018 | 53 | 0.360 |
Why?
| | Insurance, Health | 4 | 2018 | 247 | 0.350 |
Why?
| | Mass Screening | 2 | 2014 | 1024 | 0.350 |
Why?
| | Herpes Zoster Vaccine | 4 | 2023 | 159 | 0.350 |
Why?
| | Multivariate Analysis | 5 | 2013 | 1443 | 0.340 |
Why?
| | Patient-Centered Care | 2 | 2013 | 477 | 0.340 |
Why?
| | Phentermine | 2 | 2019 | 8 | 0.340 |
Why?
| | Prevalence | 9 | 2022 | 2270 | 0.340 |
Why?
| | Heart Defects, Congenital | 3 | 2020 | 660 | 0.340 |
Why?
| | Premature Birth | 2 | 2023 | 278 | 0.330 |
Why?
| | Anti-Obesity Agents | 2 | 2019 | 45 | 0.330 |
Why?
| | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 3 | 2018 | 15 | 0.320 |
Why?
| | Proportional Hazards Models | 7 | 2021 | 1088 | 0.320 |
Why?
| | Natural Language Processing | 2 | 2019 | 71 | 0.320 |
Why?
| | Pandemics | 5 | 2023 | 1337 | 0.310 |
Why?
| | Insurance, Health, Reimbursement | 3 | 2014 | 88 | 0.310 |
Why?
| | Risk | 6 | 2022 | 829 | 0.300 |
Why?
| | Logistic Models | 7 | 2019 | 1863 | 0.290 |
Why?
| | Rotavirus Infections | 3 | 2021 | 50 | 0.290 |
Why?
| | Vaccines, Synthetic | 3 | 2021 | 124 | 0.280 |
Why?
| | Vaccines, Combined | 4 | 2023 | 46 | 0.280 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 1115 | 0.280 |
Why?
| | Autism Spectrum Disorder | 2 | 2022 | 322 | 0.260 |
Why?
| | Meningococcal Vaccines | 4 | 2022 | 49 | 0.250 |
Why?
| | Cluster Analysis | 2 | 2023 | 466 | 0.250 |
Why?
| | Travel | 2 | 2023 | 121 | 0.250 |
Why?
| | Poisson Distribution | 5 | 2018 | 72 | 0.240 |
Why?
| | Seizures | 3 | 2018 | 344 | 0.240 |
Why?
| | Guillain-Barre Syndrome | 3 | 2014 | 21 | 0.240 |
Why?
| | Neoplasms | 1 | 2018 | 2114 | 0.240 |
Why?
| | Physicians, Family | 3 | 2011 | 202 | 0.230 |
Why?
| | International Classification of Diseases | 2 | 2020 | 118 | 0.230 |
Why?
| | Gastrointestinal Diseases | 3 | 2018 | 184 | 0.230 |
Why?
| | Models, Theoretical | 2 | 2020 | 520 | 0.230 |
Why?
| | Epidural Neoplasms | 1 | 2003 | 1 | 0.230 |
Why?
| | Time Factors | 13 | 2022 | 6182 | 0.220 |
Why?
| | Tetanus | 1 | 2023 | 25 | 0.220 |
Why?
| | Herpes Zoster | 2 | 2023 | 333 | 0.220 |
Why?
| | Regression Analysis | 3 | 2014 | 960 | 0.220 |
Why?
| | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2022 | 4 | 0.220 |
Why?
| | Prospective Studies | 8 | 2023 | 6276 | 0.220 |
Why?
| | Internal Medicine | 3 | 2010 | 211 | 0.220 |
Why?
| | Library Surveys | 1 | 2022 | 1 | 0.210 |
Why?
| | Cholera Vaccines | 1 | 2022 | 1 | 0.210 |
Why?
| | Chorioamnionitis | 1 | 2023 | 36 | 0.210 |
Why?
| | Typhoid-Paratyphoid Vaccines | 1 | 2022 | 4 | 0.210 |
Why?
| | Burkitt Lymphoma | 1 | 2003 | 52 | 0.210 |
Why?
| | Cholera | 1 | 2022 | 7 | 0.210 |
Why?
| | Chickenpox Vaccine | 4 | 2022 | 69 | 0.210 |
Why?
| | Sentinel Surveillance | 2 | 2016 | 38 | 0.210 |
Why?
| | Health Planning Guidelines | 1 | 2022 | 25 | 0.200 |
Why?
| | Seizures, Febrile | 1 | 2022 | 19 | 0.200 |
Why?
| | Urticaria | 1 | 2022 | 51 | 0.200 |
Why?
| | Influenza A Virus, H1N1 Subtype | 3 | 2013 | 139 | 0.200 |
Why?
| | Aged | 15 | 2023 | 19292 | 0.200 |
Why?
| | Exanthema | 1 | 2022 | 77 | 0.200 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2022 | 76 | 0.200 |
Why?
| | Minnesota | 3 | 2017 | 134 | 0.200 |
Why?
| | Hepatitis A Vaccines | 2 | 2019 | 15 | 0.200 |
Why?
| | Rotavirus | 1 | 2021 | 22 | 0.190 |
Why?
| | Pharmacoepidemiology | 1 | 2021 | 20 | 0.190 |
Why?
| | Infant, Small for Gestational Age | 1 | 2022 | 75 | 0.190 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2014 | 213 | 0.190 |
Why?
| | Body Height | 1 | 2022 | 182 | 0.190 |
Why?
| | Arachis | 1 | 2022 | 149 | 0.190 |
Why?
| | Weight Loss | 3 | 2019 | 633 | 0.180 |
Why?
| | Papillomaviridae | 2 | 2018 | 100 | 0.180 |
Why?
| | Models, Statistical | 4 | 2023 | 612 | 0.180 |
Why?
| | Bursitis | 1 | 2020 | 8 | 0.180 |
Why?
| | Case-Control Studies | 10 | 2021 | 3054 | 0.180 |
Why?
| | Pyelonephritis | 1 | 2020 | 7 | 0.180 |
Why?
| | Managed Care Programs | 4 | 2015 | 135 | 0.180 |
Why?
| | Antigens | 2 | 2021 | 322 | 0.180 |
Why?
| | Immunologic Factors | 1 | 2022 | 219 | 0.180 |
Why?
| | Cephalexin | 1 | 2020 | 8 | 0.180 |
Why?
| | Cystitis | 1 | 2020 | 20 | 0.180 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 39 | 0.170 |
Why?
| | Interrupted Time Series Analysis | 1 | 2020 | 45 | 0.170 |
Why?
| | Hepatitis A Virus, Human | 1 | 2019 | 2 | 0.170 |
Why?
| | Public Health | 2 | 2022 | 438 | 0.170 |
Why?
| | Socioeconomic Factors | 2 | 2020 | 1088 | 0.170 |
Why?
| | Hepatitis A | 1 | 2019 | 27 | 0.170 |
Why?
| | Medical Record Linkage | 1 | 2020 | 53 | 0.170 |
Why?
| | Epidemiological Monitoring | 1 | 2019 | 47 | 0.170 |
Why?
| | Vaccine Potency | 1 | 2019 | 6 | 0.170 |
Why?
| | California | 2 | 2019 | 368 | 0.170 |
Why?
| | Appetite Depressants | 1 | 2019 | 18 | 0.170 |
Why?
| | Libraries, Medical | 1 | 2019 | 9 | 0.170 |
Why?
| | Intention | 1 | 2020 | 143 | 0.170 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2416 | 0.160 |
Why?
| | Dermatitis, Atopic | 1 | 2022 | 337 | 0.160 |
Why?
| | Delivery of Health Care, Integrated | 3 | 2021 | 231 | 0.160 |
Why?
| | Sunburn | 1 | 2018 | 25 | 0.160 |
Why?
| | Nevus | 1 | 2018 | 26 | 0.160 |
Why?
| | Patient Participation | 2 | 2012 | 362 | 0.160 |
Why?
| | Physicians | 4 | 2012 | 777 | 0.160 |
Why?
| | Environment | 1 | 2020 | 340 | 0.160 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2018 | 30 | 0.160 |
Why?
| | Self Report | 1 | 2022 | 700 | 0.160 |
Why?
| | Condylomata Acuminata | 1 | 2018 | 6 | 0.150 |
Why?
| | Shoulder Joint | 1 | 2020 | 160 | 0.150 |
Why?
| | Communicable Diseases | 1 | 2020 | 130 | 0.150 |
Why?
| | Sex Factors | 3 | 2021 | 1741 | 0.150 |
Why?
| | New Zealand | 1 | 2018 | 48 | 0.150 |
Why?
| | Infant, Premature | 1 | 2022 | 477 | 0.150 |
Why?
| | Biometry | 1 | 2018 | 63 | 0.150 |
Why?
| | Thrombosis | 1 | 2021 | 302 | 0.150 |
Why?
| | Odds Ratio | 6 | 2019 | 968 | 0.150 |
Why?
| | Rhinitis, Allergic | 1 | 2018 | 37 | 0.150 |
Why?
| | Blood Pressure Determination | 2 | 2015 | 123 | 0.150 |
Why?
| | Parental Consent | 2 | 2014 | 22 | 0.150 |
Why?
| | United Kingdom | 1 | 2018 | 230 | 0.150 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2018 | 61 | 0.150 |
Why?
| | Cost-Benefit Analysis | 3 | 2015 | 548 | 0.150 |
Why?
| | Australia | 1 | 2018 | 206 | 0.150 |
Why?
| | Firearms | 1 | 2022 | 292 | 0.150 |
Why?
| | Health Status Disparities | 1 | 2019 | 207 | 0.140 |
Why?
| | Hospitalization | 4 | 2020 | 1764 | 0.140 |
Why?
| | Siblings | 1 | 2018 | 223 | 0.140 |
Why?
| | Body Weight | 2 | 2018 | 868 | 0.140 |
Why?
| | Family Health | 1 | 2018 | 199 | 0.140 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2021 | 289 | 0.140 |
Why?
| | Health Maintenance Organizations | 2 | 2014 | 96 | 0.140 |
Why?
| | Vaccines, Conjugate | 3 | 2022 | 60 | 0.140 |
Why?
| | Maternal Exposure | 1 | 2018 | 138 | 0.140 |
Why?
| | Diagnostic Errors | 1 | 2018 | 151 | 0.140 |
Why?
| | Diastole | 1 | 2017 | 135 | 0.140 |
Why?
| | Cardiovascular Diseases | 2 | 2019 | 1724 | 0.140 |
Why?
| | Cross-Sectional Studies | 8 | 2022 | 4447 | 0.140 |
Why?
| | Systole | 1 | 2017 | 169 | 0.140 |
Why?
| | United States Food and Drug Administration | 3 | 2021 | 173 | 0.140 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2017 | 152 | 0.130 |
Why?
| | Reproducibility of Results | 3 | 2019 | 2807 | 0.130 |
Why?
| | Pilot Projects | 2 | 2022 | 1379 | 0.130 |
Why?
| | Health Services Research | 3 | 2022 | 377 | 0.130 |
Why?
| | Registries | 4 | 2011 | 1772 | 0.130 |
Why?
| | Ultraviolet Rays | 1 | 2018 | 372 | 0.130 |
Why?
| | Data Accuracy | 1 | 2016 | 50 | 0.130 |
Why?
| | Public Health Surveillance | 3 | 2020 | 61 | 0.130 |
Why?
| | Needs Assessment | 1 | 2017 | 320 | 0.130 |
Why?
| | Focus Groups | 2 | 2014 | 387 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 344 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 336 | 0.120 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2021 | 3258 | 0.120 |
Why?
| | Breast Feeding | 1 | 2018 | 370 | 0.120 |
Why?
| | Contraceptives, Oral | 1 | 2014 | 25 | 0.120 |
Why?
| | Social Welfare | 1 | 2014 | 20 | 0.120 |
Why?
| | Adjuvants, Immunologic | 1 | 2015 | 206 | 0.120 |
Why?
| | Direct Service Costs | 1 | 2014 | 10 | 0.120 |
Why?
| | Program Evaluation | 1 | 2018 | 841 | 0.120 |
Why?
| | Food Hypersensitivity | 1 | 2018 | 254 | 0.110 |
Why?
| | Respiratory Tract Infections | 2 | 2018 | 323 | 0.110 |
Why?
| | Research Design | 4 | 2022 | 949 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2019 | 450 | 0.110 |
Why?
| | Costs and Cost Analysis | 1 | 2014 | 200 | 0.110 |
Why?
| | Aged, 80 and over | 7 | 2020 | 6434 | 0.110 |
Why?
| | Dyslipidemias | 1 | 2014 | 155 | 0.110 |
Why?
| | Health Promotion | 1 | 2019 | 690 | 0.110 |
Why?
| | Follow-Up Studies | 5 | 2020 | 4443 | 0.100 |
Why?
| | Computer Simulation | 2 | 2013 | 882 | 0.100 |
Why?
| | Maternal Age | 2 | 2023 | 117 | 0.100 |
Why?
| | Venous Thromboembolism | 1 | 2015 | 234 | 0.100 |
Why?
| | Health Services | 1 | 2013 | 104 | 0.100 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2012 | 12 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2015 | 380 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 905 | 0.100 |
Why?
| | RNA, Messenger | 3 | 2023 | 2581 | 0.100 |
Why?
| | Mass Vaccination | 1 | 2011 | 15 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2018 | 760 | 0.100 |
Why?
| | Evidence-Based Medicine | 1 | 2015 | 685 | 0.090 |
Why?
| | Prescriptions | 2 | 2022 | 60 | 0.090 |
Why?
| | Health Care Costs | 1 | 2014 | 384 | 0.090 |
Why?
| | Respiratory Syncytial Virus, Human | 2 | 2023 | 60 | 0.090 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2010 | 37 | 0.090 |
Why?
| | Drug Recalls | 1 | 2010 | 5 | 0.090 |
Why?
| | Medical Records Systems, Computerized | 1 | 2011 | 90 | 0.090 |
Why?
| | Physicians, Primary Care | 1 | 2013 | 222 | 0.090 |
Why?
| | Haemophilus influenzae | 1 | 2010 | 50 | 0.090 |
Why?
| | Haemophilus Infections | 1 | 2010 | 30 | 0.090 |
Why?
| | Feasibility Studies | 1 | 2013 | 750 | 0.090 |
Why?
| | Medicare Part D | 1 | 2010 | 25 | 0.090 |
Why?
| | Polysaccharides, Bacterial | 1 | 2010 | 65 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 1842 | 0.090 |
Why?
| | Communication | 1 | 2015 | 749 | 0.090 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2010 | 58 | 0.090 |
Why?
| | Immunization, Secondary | 4 | 2013 | 82 | 0.090 |
Why?
| | Pertussis Vaccine | 1 | 2009 | 21 | 0.080 |
Why?
| | Patient Education as Topic | 2 | 2011 | 685 | 0.080 |
Why?
| | Autistic Disorder | 1 | 2011 | 163 | 0.080 |
Why?
| | Pregnancy Outcome | 2 | 2023 | 336 | 0.080 |
Why?
| | Chickenpox | 1 | 2010 | 94 | 0.080 |
Why?
| | Data Interpretation, Statistical | 2 | 2021 | 325 | 0.080 |
Why?
| | Anemia, Sickle Cell | 1 | 2011 | 221 | 0.080 |
Why?
| | Disease Susceptibility | 2 | 2020 | 321 | 0.080 |
Why?
| | Neuralgia, Postherpetic | 1 | 2008 | 44 | 0.080 |
Why?
| | Observational Studies as Topic | 2 | 2018 | 89 | 0.070 |
Why?
| | Confidence Intervals | 2 | 2021 | 309 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2019 | 1725 | 0.070 |
Why?
| | Mortality | 2 | 2019 | 290 | 0.070 |
Why?
| | Risk-Taking | 1 | 2009 | 332 | 0.070 |
Why?
| | Health Surveys | 3 | 2017 | 447 | 0.060 |
Why?
| | Cause of Death | 2 | 2019 | 368 | 0.060 |
Why?
| | Urban Health | 1 | 2005 | 75 | 0.060 |
Why?
| | Rural Health | 1 | 2005 | 68 | 0.060 |
Why?
| | HIV Infections | 1 | 2019 | 2471 | 0.060 |
Why?
| | Probability | 1 | 2005 | 295 | 0.060 |
Why?
| | Office Automation | 1 | 2004 | 4 | 0.060 |
Why?
| | Patient Selection | 1 | 2007 | 655 | 0.060 |
Why?
| | Public Health Practice | 1 | 2004 | 63 | 0.060 |
Why?
| | Epidural Space | 1 | 2003 | 6 | 0.060 |
Why?
| | Toxoids | 1 | 2023 | 1 | 0.060 |
Why?
| | Spinal Cord Compression | 1 | 2003 | 17 | 0.060 |
Why?
| | Herpesvirus 3, Human | 2 | 2023 | 381 | 0.060 |
Why?
| | Patient Care | 1 | 2004 | 103 | 0.060 |
Why?
| | Health Services Accessibility | 1 | 2009 | 771 | 0.050 |
Why?
| | Vibrio cholerae O1 | 1 | 2022 | 1 | 0.050 |
Why?
| | Travel-Related Illness | 1 | 2022 | 6 | 0.050 |
Why?
| | Antacids | 1 | 2022 | 15 | 0.050 |
Why?
| | Blood Group Antigens | 1 | 2022 | 14 | 0.050 |
Why?
| | Drug Utilization | 2 | 2013 | 167 | 0.050 |
Why?
| | Dehydration | 1 | 2022 | 38 | 0.050 |
Why?
| | Measles Vaccine | 1 | 2022 | 17 | 0.050 |
Why?
| | Algorithms | 2 | 2020 | 1494 | 0.050 |
Why?
| | Family Characteristics | 1 | 2023 | 154 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2019 | 9163 | 0.050 |
Why?
| | Information Systems | 1 | 2021 | 61 | 0.050 |
Why?
| | Safety-Based Drug Withdrawals | 1 | 2021 | 2 | 0.050 |
Why?
| | Office Visits | 2 | 2015 | 79 | 0.050 |
Why?
| | Drug Labeling | 1 | 2021 | 42 | 0.050 |
Why?
| | Health Policy | 1 | 2004 | 332 | 0.050 |
Why?
| | Bacterial Capsules | 1 | 2020 | 28 | 0.050 |
Why?
| | Epidemiologic Research Design | 2 | 2013 | 27 | 0.050 |
Why?
| | Deltoid Muscle | 1 | 2020 | 4 | 0.050 |
Why?
| | Fever | 1 | 2022 | 280 | 0.050 |
Why?
| | Insurance Claim Reporting | 1 | 2020 | 22 | 0.040 |
Why?
| | Injections, Intramuscular | 1 | 2020 | 118 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 278 | 0.040 |
Why?
| | Evidence-Based Practice | 1 | 2021 | 191 | 0.040 |
Why?
| | Epidemiologic Methods | 1 | 2019 | 73 | 0.040 |
Why?
| | Graphic Novels as Topic | 1 | 2019 | 1 | 0.040 |
Why?
| | Child Health Services | 1 | 2022 | 180 | 0.040 |
Why?
| | Water | 1 | 2022 | 413 | 0.040 |
Why?
| | Student Health Services | 1 | 2019 | 16 | 0.040 |
Why?
| | Florida | 1 | 2019 | 73 | 0.040 |
Why?
| | Orthomyxoviridae | 1 | 2019 | 35 | 0.040 |
Why?
| | Antihypertensive Agents | 1 | 2022 | 432 | 0.040 |
Why?
| | History, 21st Century | 1 | 2019 | 164 | 0.040 |
Why?
| | Gestational Age | 1 | 2021 | 757 | 0.040 |
Why?
| | Pancreatitis | 1 | 2019 | 107 | 0.040 |
Why?
| | Medical Informatics | 1 | 2019 | 94 | 0.040 |
Why?
| | Birth Weight | 1 | 2021 | 438 | 0.040 |
Why?
| | Patient Safety | 1 | 2022 | 276 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 454 | 0.040 |
Why?
| | Appendicitis | 1 | 2019 | 110 | 0.040 |
Why?
| | Stillbirth | 1 | 2018 | 57 | 0.040 |
Why?
| | Croup | 1 | 2018 | 22 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2018 | 140 | 0.040 |
Why?
| | Minority Groups | 1 | 2019 | 232 | 0.040 |
Why?
| | Linear Models | 1 | 2019 | 777 | 0.040 |
Why?
| | Propensity Score | 1 | 2018 | 225 | 0.030 |
Why?
| | Universities | 1 | 2019 | 341 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 724 | 0.030 |
Why?
| | Prediabetic State | 1 | 2019 | 225 | 0.030 |
Why?
| | Social Class | 1 | 2018 | 210 | 0.030 |
Why?
| | Respiratory Sounds | 1 | 2017 | 114 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1217 | 0.030 |
Why?
| | Otitis Media | 1 | 2018 | 142 | 0.030 |
Why?
| | Government Programs | 1 | 2015 | 22 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 1360 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1813 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2014 | 185 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2015 | 204 | 0.030 |
Why?
| | Off-Label Use | 1 | 2013 | 52 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3344 | 0.030 |
Why?
| | Cholesterol, LDL | 1 | 2014 | 309 | 0.030 |
Why?
| | Quality Control | 1 | 2012 | 150 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2013 | 177 | 0.030 |
Why?
| | Tetanus Toxoid | 1 | 2012 | 37 | 0.030 |
Why?
| | Triglycerides | 1 | 2014 | 471 | 0.030 |
Why?
| | Encephalitis | 1 | 2014 | 128 | 0.030 |
Why?
| | Professional Practice Location | 1 | 2011 | 26 | 0.020 |
Why?
| | Survival Rate | 1 | 2016 | 1649 | 0.020 |
Why?
| | Bell Palsy | 1 | 2011 | 6 | 0.020 |
Why?
| | Physical Examination | 1 | 2013 | 224 | 0.020 |
Why?
| | Medically Uninsured | 1 | 2012 | 122 | 0.020 |
Why?
| | Comorbidity | 1 | 2016 | 1476 | 0.020 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2010 | 11 | 0.020 |
Why?
| | Income | 1 | 2012 | 170 | 0.020 |
Why?
| | Schools | 1 | 2014 | 399 | 0.020 |
Why?
| | Pharmaceutical Services | 1 | 2011 | 79 | 0.020 |
Why?
| | Fees, Pharmaceutical | 1 | 2010 | 13 | 0.020 |
Why?
| | Job Satisfaction | 1 | 2011 | 170 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2590 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2011 | 391 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2011 | 595 | 0.020 |
Why?
| | Postal Service | 1 | 2008 | 30 | 0.020 |
Why?
| | Health Behavior | 1 | 2013 | 704 | 0.020 |
Why?
| | Health Care Rationing | 1 | 2007 | 47 | 0.020 |
Why?
| | Efficiency, Organizational | 1 | 2008 | 126 | 0.020 |
Why?
| | Demography | 1 | 2008 | 264 | 0.020 |
Why?
| | Intussusception | 1 | 2007 | 27 | 0.020 |
Why?
| | Mass Media | 1 | 2005 | 38 | 0.020 |
Why?
| | Perception | 1 | 2007 | 316 | 0.010 |
Why?
| | Policy Making | 1 | 2004 | 82 | 0.010 |
Why?
|
|
Daley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|